Watchlist Price Alert

Theravance Biopharma Inc. (TBPH)

NASDAQ: TBPH · Real-Time Price · USD

8.96

-0.94 (-9.49%)

At close: May 09, 2025, 3:59 PM

9.00

0.39%

After-hours: May 09, 2025, 06:46 PM EDT

Theravance Biopharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	37.8M	39.55M	298.17M	89.96M	81.47M	58.06M	378.02M	88.98M	344.71M
Short-Term Investments	50.55M	62.88M	29.31M	83.51M	211.47M	222.77M	127.25M	259.59M	156.39M
Long-Term Investments	n/a	n/a	836K	67.54M	12.75M	4.99M	11.87M	41.59M	91.56M
Other Long-Term Assets	157.32M	203.1M	201.1M	4.07M	3.28M	6.11M	2.37M	10.91M	10.73M
Receivables	68.44M	17.47M	16.79M	57.6M	69.67M	n/a	10.67M	9.36M	9.72M
Inventory	n/a	n/a	1.51M	10.24M	20.37M	n/a	n/a	16.83M	12.22M
Other Current Assets	4.2M	11.6M	7.68M	8.56M	10.36M	57.66M	n/a	3.7M	2.4M
Total Current Assets	161.07M	133.54M	353.46M	249.87M	393.34M	338.49M	532.82M	378.75M	528.5M
Property-Plant & Equipment	35.77M	45.35M	52M	53.35M	59.68M	59.25M	13.18M	10.16M	8.46M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	193.09M	248.46M	253.94M	124.95M	75.72M	70.34M	27.41M	62.65M	110.75M
Total Assets	354.16M	382M	607.4M	374.82M	469.06M	408.83M	560.24M	441.4M	639.25M
Account Payables	2.24M	1.52M	1.55M	3.1M	6.78M	4.76M	9.03M	5.92M	1.73M
Deferred Revenue	n/a	n/a	24K	98K	11.52M	31.57M	43.4M	125K	152K
Short-Term Debt	10.71M	n/a	n/a	16.94M	19.33M	17.61M	n/a	n/a	n/a
Other Current Liabilities	19.13M	12.88M	10.07M	50.3M	81.67M	29.58M	22.32M	32.37M	33.36M
Total Current Liabilities	32.09M	24.77M	28.71M	58.59M	123.57M	111.7M	98.55M	62.55M	49.27M
Long-Term Debt	n/a	n/a	45.41M	599.39M	599.84M	445.19M	454.35M	223.75M	222.68M
Other Long-Term Liabilities	146.53M	99M	45.88M	2.42M	1.83M	21.29M	32.74M	39.92M	17.08M
Total Long-Term Liabilities	146.53M	144.24M	136.88M	654.8M	649.24M	520.96M	513.27M	263.67M	239.75M
Total Liabilities	178.62M	169M	165.6M	713.39M	772.81M	632.67M	611.82M	326.22M	289.02M
Total Debt	49.82M	49.16M	74.12M	652.08M	647.06M	492.92M	454.35M	223.75M	222.68M
Common Stock	n/a	n/a	1K	1K	1K	1K	1K	1K	1K
Retained Earnings	-965.52M	-909.1M	-853.91M	-1.73B	-1.53B	-1.25B	-1.01B	-797.74M	-512.23M
Comprehensive Income	7K	-65K	-15K	-0.00	47K	145K	-166K	-733K	-253K
Shareholders Equity	175.54M	213M	441.8M	-338.57M	-303.75M	-223.84M	-51.59M	115.18M	350.23M
Total Investments	50.55M	62.88M	29.31M	151.04M	224.22M	227.75M	139.12M	301.17M	255.95M